Skip to main content
. 2015 Jul 30;6(28):25226–25239. doi: 10.18632/oncotarget.4712

Figure 1. UBE2T is overexpressed and related to the prognosis of prostate cancer patients.

Figure 1

A. Immunohistochemical analysis of UBE2T levels in different stages of prostate cancer in a tissue array. From left to right are representative images of UBE2T expression in normal tissue, prostate cancer tissues without or with metastasis. Normal: normal tissues; No distant metastasis: cancer tissues without distant metastasis; Distant metastasis: cancer tissues with distant metastasis. Lower panels are the higher magnification of indicated areas in upper panel. B. Analysis of UBE2T positive cells in the above prostate cancer tissue array. C. Survival analysis of patients with prostate cancers in a publically available dataset (GSE21032). Scale bars, 100 μm (A upper panel) and 20 μm (A lower panel). **P < 0.01 in panel B based on the Student t test. Error bars, SD.